CRBU
Caribou Biosciences Inc.
$2.42
+$0.10(+4.31%)
47
Overall
60
Value
58
Tech
23
Quality
Market Cap
$230.01M
Volume
564.41K
52W Range
$0.66 - $3.00
Target Price
$8.86
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Total Revenue | $9.6M | $13.9M | $34.5M | $10.0M | ||
| Total Revenue | $9.6M | $13.9M | $34.5M | $10.0M | ||
| GROSS PROFIT | ||||||
| Gross Profit | $9.6M | $13.9M | $34.5M | $10.0M | ||
| OPERATING EXPENSES | ||||||
| Operating Expenses | $76.6M | $120.3M | $150.5M | $176.6M | ||
| Research & Development | $52.3M | $82.2M | $112.1M | $130.2M | ||
| Research Expense | $52.3M | $82.2M | $112.1M | $130.2M | ||
| Selling, General & Administrative | $24.3M | $38.0M | $38.5M | $46.5M | ||
| General & Administrative Expenses | $24.3M | $38.0M | $38.5M | $46.5M | ||
| Salaries & Wages | $3.4M | -- | $13.8M | $16.7M | ||
| Other Operating Expenses | $-869.0K | $-847.0K | $-1.3M | $-2.7M | ||
| OPERATING INCOME | ||||||
| Operating income | $-67.0M | $-106.4M | $-116.1M | $-166.6M | ||
| EBITDA | $-65.6M | $-104.8M | $-98.4M | $-145.2M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $8.0K | -- | -- | -- | ||
| Intinc | $148.0K | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $140.0K | -- | -- | -- | ||
| Gain on Sale of Securities | -- | $-133.0K | $-6.0K | -- | ||
| Other Income/Expense | $-377.0K | $7.0M | $-15.5M | $-15.3M | ||
| Other Special Charges | $377.0K | $7.2M | $15.5M | $15.3M | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-66.6M | $-106.4M | $-101.9M | $-149.1M | ||
| Pre-Tax Income | $-66.6M | $-99.4M | $-101.9M | $-149.1M | ||
| INCOME TAX | ||||||
| Tax Provision | $321.0K | $70.0K | $193.0K | $-9.0K | ||
| NET INCOME | ||||||
| Net Income | $-66.9M | $-99.4M | $-102.1M | $-149.1M | ||
| Net Income (Continuing Operations) | $-66.9M | $-99.4M | $-102.1M | $-149.1M | ||
| Net Income (Discontinued Operations) | $-66.9M | $-99.4M | $-102.1M | $-149.1M | ||
| Net Income (Common Stockholders) | $-66.9M | $-99.4M | $-102.1M | $-149.1M | ||
| Normalized Income | $-52.6M | -- | -- | $-149.1M | ||
| TOTALS | ||||||
| Total Expenses | $76.6M | $120.3M | $150.5M | $176.6M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $31.7M | $60.8M | $73.8M | $90.3M | ||
| Average Shares Outstanding (Diluted) | -- | $60.8M | $73.8M | $90.3M | ||
| Shares Outstanding | $60.7M | $61.3M | $90.3M | $93.0M | ||
| Basic EPS | $-2.11 | $-1.64 | $-1.38 | $-1.65 | ||
| Basic EPS (Continuing Operations) | $-2.11 | $-1.64 | $-1.38 | $-1.65 | ||
| Diluted EPS | $-2.11 | $-1.64 | $-1.38 | $-1.65 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.64 | $-1.38 | $-1.65 | ||
| OTHER METRICS | ||||||
| Other Gand A | $24.3M | $38.0M | $38.5M | $46.5M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRBU | $2.42 | +4.3% | 564.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Caribou Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW